So, this suggests that autophagy in cancer cells is a protective reaction to anti-tumor agents, and a disrupted autophagy pathway may enhance the cytotoxicity of LSD1 inhibitor in prostate cancer cells. The gene discussed is KDM1A; the disease is prostate carcinoma.